|
 Erol Onel, M.D. is an experienced physician with strong clinical and academic background coupled with industry experience (all phases: 1, 2, 3a, 3b, and 4 in both large and small pharmaceutical companies) and corporate/market focus, who can bring leadership across therapeutic areas, speed drugs and devices to market, and expand product life-cycles.
Erol Onel, M.D. Director, Medical Affairs (Surgical Sub-Specialties, Urology, Orthopaedics)
- Started and provided scientific leadership to Urology division; provided scientific leadership to Orthopaedics division
- Founded team to purchase initial Urology product; doubled sales from $7 Million to $15 Million
- Dramatically increased main Orthopaedic product revenue from $14 Million in 2006 to $36 Million in 2007, partially due to inclusion of Rheumatologists, PCPs, and PMR specialists
- Managed successful interactions with FDA and EMEA with team of 14 MDs, PhDs, RNs, and MBAs resulting in approval of New Chemical Entity (Degarelix) for treatment of prostate cancer
- Compiled and prioritized existing and new data into cogent and profitable action plans
- Authored and designed clinical development plans, study protocols, and training materials
- Established external presence with manuscripts, abstracts, and presentations at international meetings (Urology: AUA, ASCO, GU Cancer Symposium, IPPS; Orthopaedics: AAOS, ACR, OARSI)
- Medical leadership to national sales force of 80 sales representatives plus telesales
- Led national advisory board meetings and provided speaker training (international faculty of 60)
- Worked with business development on identification and due diligence of new acquisitions
- Initiated plan with Europe to rescue pipeline products
- Assimilated and critically evaluated physician, managed care, and consumer input to partner with sales and marketing in creation of new, scientifically-based advertising campaign
- Critical role in facilitating and maintaining positive inter-departmental communications (notably with regulatory, marketing, sales, sales training, manufacturing, managed care, distribution, and legal departments) and external communications with vendors, agencies, and KOLs
|
